about
Is there an alternative to quality-adjusted life years for supporting healthcare decision making?Cost-effectiveness of psoriasis therapy with etanercept in Germany.Cost-effectiveness sequential modeling of ranibizumab versus usual care in age-related macular degeneration.Current challenges in health economic modeling of cancer therapies: a research inquiry.Assessment of the cost-effectiveness and clinical outcomes of a fourth-generation synchronous telehealth program for the management of chronic cardiovascular disease.Modelling cost-effectiveness of biologic treatments based on disease activity scores for the management of rheumatoid arthritis in Spain.Cost-effectiveness modelling of sequential biologic strategies for the treatment of moderate to severe rheumatoid arthritis in Finland.Health economic evaluations alongside clinical trials: a review of study protocols at the Swedish Medical Products Agency.A comparison of the superficial inferior epigastric artery flap and deep inferior epigastric perforator flap in postmastectomy reconstruction: A cost-effectiveness analysis.Users' guide to the orthopaedic literature: what is a cost-effectiveness analysis?Theory of constraints for publicly funded health systems.Quality-adjusted life-years as decisionmaker tools to address limitations inherent in number-needed-to-treat/harm values.Validation of the underlying assumptions of the quality-adjusted life-years outcome: results from the ECHOUTCOME European project.A stochastic multicriteria model for evidence-based decision making in drug benefit-risk analysis.Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity.The Economic Attractiveness of Targeted Radiotherapy: Value for Money?
P2860
Q30387584-59B5E42E-5F0A-4E91-9A25-B426EDEC5731Q33296076-F3767971-9868-498A-A9E7-4858783EDECDQ33353392-5B85F35D-8DBD-4214-9BB6-3B7A66E4F912Q33805471-7BBFC181-4DCA-4792-A0AF-1E5F19235A0CQ33807769-52E0F147-80AE-459A-8AD6-6EA5ED0AD317Q35113679-BAB5C685-036E-4AE8-99FB-0019FF9BAA8AQ35952231-DAD0772F-6CE1-440E-8474-0431603FC3C2Q36853742-E45D26CA-085C-49D4-8A9C-E4E3CD917D8EQ37214759-99BDA21D-607B-4978-AC45-1970BF5EFE65Q37381626-9B4076B4-ED17-440B-8832-9D5A6ACFFC92Q39566500-C90788CC-A77E-4F78-83B4-C4D4B1159AB0Q43526375-250EAD1A-54E4-4AB4-8096-4A52049D8F08Q43812541-4C4408A9-698A-4AF2-B15D-66300374FD78Q44827816-A742A73C-F8A5-4418-B0E3-6C9DFB8FD830Q46116604-2E2E8EFB-1DB5-49A9-A9B5-FD56B345EF6FQ58758454-1A5F8AFE-2714-4870-8917-B845A85D4273
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
QALYs: are they helpful to decision makers?
@ast
QALYs: are they helpful to decision makers?
@en
type
label
QALYs: are they helpful to decision makers?
@ast
QALYs: are they helpful to decision makers?
@en
prefLabel
QALYs: are they helpful to decision makers?
@ast
QALYs: are they helpful to decision makers?
@en
P1433
P1476
QALYs: are they helpful to decision makers?
@en
P2093
Maurice McGregor
P304
P356
10.2165/00019053-200624100-00002
P50
P577
2006-01-01T00:00:00Z
P6179
1053282726